Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin

BACKGROUND: People who have had a transient ischaemic attack (TIA) or non‐disabling ischaemic stroke have an annual risk of major vascular events of between 4% and 11%. Aspirin reduces this risk by 20% at most. Secondary prevention trials after myocardial infarction indicate that treatment with vita...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cochrane Database Syst Rev
Autores principales: De Schryver, Els LLM, Algra, Ale, Kappelle, L Jaap, van Gijn, Jan, Koudstaal, Peter J
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Ltd 2012
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7055052/
https://ncbi.nlm.nih.gov/pubmed/22972051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001342.pub3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares